VEGFA and colonic neoplasm: The silymarin, silibinin (SB), and thalidomide attenuated proliferation in endothelial (EA.hy 926) and colon cancer (LoVo) cell lines and also reduced the LoVo-secreting VEGF (Yang et al., 2003).